Molecular Blood Test Diagnoses Herpes Simplex Virus Infection
|
By LabMedica International staff writers Posted on 07 Nov 2012 |
Polymerase chain reaction (PCR) is now the test of choice for identifying central nervous system infection caused by herpes simplex virus (HSV).
A longitudinal review of HSV PCR testing at two pediatric academic medical centers in the USA determined the clinical features of children positive for serum HSV through PCR testing.
Scientists at the University of Texas Southwestern Medical Center (Dallas, TX, USA) in collaboration with others carried out a retrospective review of all patients who had a serum HSV PCR test at the participating institutions from 2005 to 2010. The study focused on children with one positive blood HSV PCR test and reviewed their charts for demographic, clinical, and other data. They defined a neonatal HSV infection as occurring before 42 days of age.
More than 700 patients received blood HSV PCR testing during the study period. Of those children, 294 were infants younger than 42 days old. A positive HSV PCR test was found in 45 patients (6.1%), 21 of whom were infants. Of these infants, approximately 25% were diagnosed with skin, eye, and mouth HSV disease; another 25% were diagnosed with central nervous system HSV disease; and approximately 50% had disseminated HSV disease. One third of the neonatal HSV patients in this study died. For two of those infants, the blood HSV PCR was the only positive HSV test. In another four children, the blood HSV PCR was the first test that was positive.
Among the 24 older children with positive blood HSV PCR tests, 50% were immunocompromised. Another 29% suffered from atopic dermatitis. Mucocutaneous lesions were much more common, occurring in 92% of these older children and 13% of the older children died. In four of the older children, the blood HSV PCR was the only positive test, and it was the first positive test in another seven of these children, all of whom had vesicular lesions that would have clinically suggested an HSV diagnosis. The authors concluded that HSV PCR testing on serum samples can be a useful adjunct in the diagnosis of HSV, especially among young infants who are much less likely than older children to have mucocutaneous lesions. The study was published in the August 2012 edition of the Journal of Pediatrics.
Related Links:
University of Texas Southwestern Medical Center
A longitudinal review of HSV PCR testing at two pediatric academic medical centers in the USA determined the clinical features of children positive for serum HSV through PCR testing.
Scientists at the University of Texas Southwestern Medical Center (Dallas, TX, USA) in collaboration with others carried out a retrospective review of all patients who had a serum HSV PCR test at the participating institutions from 2005 to 2010. The study focused on children with one positive blood HSV PCR test and reviewed their charts for demographic, clinical, and other data. They defined a neonatal HSV infection as occurring before 42 days of age.
More than 700 patients received blood HSV PCR testing during the study period. Of those children, 294 were infants younger than 42 days old. A positive HSV PCR test was found in 45 patients (6.1%), 21 of whom were infants. Of these infants, approximately 25% were diagnosed with skin, eye, and mouth HSV disease; another 25% were diagnosed with central nervous system HSV disease; and approximately 50% had disseminated HSV disease. One third of the neonatal HSV patients in this study died. For two of those infants, the blood HSV PCR was the only positive HSV test. In another four children, the blood HSV PCR was the first test that was positive.
Among the 24 older children with positive blood HSV PCR tests, 50% were immunocompromised. Another 29% suffered from atopic dermatitis. Mucocutaneous lesions were much more common, occurring in 92% of these older children and 13% of the older children died. In four of the older children, the blood HSV PCR was the only positive test, and it was the first positive test in another seven of these children, all of whom had vesicular lesions that would have clinically suggested an HSV diagnosis. The authors concluded that HSV PCR testing on serum samples can be a useful adjunct in the diagnosis of HSV, especially among young infants who are much less likely than older children to have mucocutaneous lesions. The study was published in the August 2012 edition of the Journal of Pediatrics.
Related Links:
University of Texas Southwestern Medical Center
Latest Microbiology News
- Machine Learning Reveals Consistent Gut Microbiome Patterns in Colorectal Cancer
- Study Reveals Widespread Community Spread of Drug-Resistant Klebsiella
- Stronger Laboratory Services Support Timely Melioidosis Diagnosis Amid Global Spread
- Extracellular Vesicle Biomarker May Enable Noninvasive Monitoring of H. pylori
- Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE
- New Protein Targets Support Diagnostics for Louse-Borne Relapsing Fever
- TORCH Infection Trends Point to Need for Tailored Screening in Pregnancy
- Automated Blood Culture System Speeds Detection of Bloodstream Infections
- New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
- Gut Microbiome Signatures Help Identify Risk of IBD Progression
- FDA-Cleared Gastrointestinal Panel Detects 24 Pathogen Targets
- New AMR Assay Supports Rapid Infection Control Screening in Hospitals
- Diagnostic Gaps Complicate Bundibugyo Ebola Outbreak Response in Congo
- Study Finds Hidden Mpox Infections May Drive Ongoing Spread
- Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals
- Molecular Urine and Stool Tests Do Not Improve Early TB Treatment in Hospitalized HIV Patients
Channels
Clinical Chemistry
view channel
FDA-Approved Test Identifies Low Risk of Large Esophageal Varices in Cirrhosis
Chronic liver disease contributes substantially to mortality, and clinicians routinely screen adults with compensated cirrhosis for varices to prevent bleeding. However, endoscopy is invasive and reso... Read more
Blood Protein Signature Diagnoses Pediatric IBD and Distinguishes Subtypes
Confirming pediatric inflammatory bowel disease (IBD) often requires imaging, endoscopy, and histopathology, prolonging time to diagnosis. Reliable, noninvasive blood tests remain an unmet need in routine... Read moreMolecular Diagnostics
view channel
Ultrasensitive ctDNA Assay Detects MRD in Breast, Colorectal, Renal Cancers
Minimal residual disease testing is increasingly used to guide adjuvant therapy and surveillance in solid tumors, but detecting very low levels of circulating tumor DNA remains challenging in routine practice.... Read more
Female-Specific RNA Biomarker May Help Explain Sex Differences in Immune Disease
Women show distinct susceptibility to infectious diseases and higher rates of autoimmune disorders, yet the molecular drivers remain unclear. This gap has limited sex-specific diagnostic and prognostic tools.... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channel
New Cellular Biomarkers Correlate with Disease Severity in Sjögren Disease
Autoimmune disorders arise when immune responses target self-antigens, driving chronic inflammation and long-term morbidity. In primary Sjögren disease, inflammation of salivary and lacrimal glands leads... Read more
Airway Immune Signature May Predict Tuberculosis Progression Risk
Tuberculosis remains difficult to predict and prevent, despite widespread exposure worldwide. An estimated quarter of the global population has been infected with Mycobacterium tuberculosis, yet only a... Read morePathology
view channel
Uncertainty-Aware AI Tool Improves Digital Pathology for Cancer Subtyping
Reliable histologic subtyping guides therapy selection in oncology, yet diagnostic workflows grow more complex as whole-slide imaging and artificial intelligence (AI) expand. A persistent obstacle to clinical... Read more
Study Highlights Biomarker Testing Delays in Lung Cancer Care
Timely biomarker results are critical to match lung cancer patients with targeted therapies or immunotherapies, yet many clinical pathways still delay testing after biopsy. Ordering responsibility, reimbursement... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Project Aims to Develop First Single-Cell Assay for ADC Therapies
Antibody-drug conjugates are expanding rapidly in oncology, intensifying the need for biomarker strategies that capture tumor heterogeneity at cellular resolution. Single-cell profiling can delineate cellular... Read more








